{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:08:12Z","timestamp":1761862092206,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.medcli.2023.05.006","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T10:09:51Z","timestamp":1686823791000},"page":"217-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gammapat\u00eda monoclonal de significado incierto"],"prefix":"10.1016","volume":"161","author":[{"given":"Elena","family":"Alejo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borja","family":"Puertas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda-Victoria","family":"Mateos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2023.05.006_bib0260","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group","volume":"121","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.medcli.2023.05.006_bib0265","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.medcli.2023.05.006_bib0270","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2141.2006.06235.x","article-title":"Monoclonal gammopathy of undetermined significance","volume":"134","author":"Kyle","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.medcli.2023.05.006_bib0275","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: A prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2023.05.006_bib0280","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.medcli.2023.05.006_bib0285","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1182\/blood-2017-09-807560","article-title":"How I manage monoclonal gammopathy of undetermined significance","volume":"131","author":"Go","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2023.05.006_bib0290","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood.2019846782","article-title":"Monoclonal gammopathy of undetermined significance","volume":"133","author":"Mouhieddine","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2023.05.006_bib0295","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of Monoclonal Gammopathy of Undetermined Significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2023.05.006_bib0300","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood-2022-163169","article-title":"Prevalence of MGUS Is High in the Istopmm Study but the Prevalence of IgA MGUS Does Not Increase with Age in the Way Other Immunoglobulin Subtypes Do","volume":"140","author":"Love","year":"2022","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2023.05.006_bib0305","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/S0025-6196(11)61089-6","article-title":"Prevalence of Monoclonal Gammopathy of Undetermined Significance Among Men in Ghana","volume":"82","author":"Landgren","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.medcli.2023.05.006_bib0310","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/leu.2014.34","article-title":"Racial disparities in the prevalence of monoclonal gammopathies: A population-based study of 12 482 persons from the National Health and Nutritional Examination Survey","volume":"28","author":"Landgren","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.medcli.2023.05.006_bib0315","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","article-title":"Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States","volume":"107","author":"Landgren","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2023.05.006_bib0320","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9343(98)00080-1","article-title":"Racial Differences in the Prevalence of Monoclonal Gammopathy in a Community-based Sample of the Elderly","volume":"104","author":"Cohen","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.medcli.2023.05.006_bib0325","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0025-6196(11)61090-2","article-title":"Prevalence of Monoclonal Gammopathy of Undetermined Significance: Study of 52,802 Persons in Nagasaki City, Japan","volume":"82","author":"Iwanaga","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.medcli.2023.05.006_bib0330","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.mayocp.2021.07.024","article-title":"Detection of Plasma Cell Disorders by Mass Spectrometry: A Comprehensive Review of 19,523 Cases","volume":"97","author":"Dasari","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.medcli.2023.05.006_bib0335","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1016\/S2352-3026(22)00069-2","article-title":"Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: A multicentre cohort study","volume":"9","author":"El-Khoury","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.medcli.2023.05.006_bib0340","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1182\/blood-2007-02-069625","article-title":"Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma","volume":"110","author":"Gonz\u00e1lez","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2023.05.006_bib0345","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrclinonc.2016.122","article-title":"Genomic complexity of multiple myeloma and its clinical implications","volume":"14","author":"Manier","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.medcli.2023.05.006_bib0350","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood-2008-12-191676","article-title":"Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden","volume":"114","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2023.05.006_bib0355","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood-2008-12-192575","article-title":"Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance","volume":"114","author":"Vachon","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2023.05.006_bib0360","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1182\/bloodadvances.2020001435","article-title":"Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance","volume":"4","author":"Clay-Gilmour","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.medcli.2023.05.006_bib0365","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41408-022-00658-w","article-title":"Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6","volume":"12","author":"Clay-Gilmour","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.medcli.2023.05.006_bib0370","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1182\/blood-2008-05-159665","article-title":"Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors","volume":"113","author":"Iwanaga","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2023.05.006_bib0375","doi-asserted-by":"crossref","first-page":"876271","DOI":"10.3389\/fimmu.2022.876271","article-title":"Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance","volume":"13","author":"Sigurbergsd\u00f3ttir","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2023.05.006_bib0380","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00277-021-04400-7","article-title":"Risk factors for monoclonal gammopathy of undetermined significance: A systematic review","volume":"100","author":"Castaneda-Avila","year":"2021","journal-title":"Ann Hematol"},{"key":"10.1016\/j.medcli.2023.05.006_bib0385","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamaoncol.2018.0509","article-title":"Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center Disaster","volume":"4","author":"Landgren","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.medcli.2023.05.006_bib0390","doi-asserted-by":"crossref","first-page":"10031","DOI":"10.1182\/blood-2022-169393","article-title":"Autoimmune Diseases Are Not Associated with Monoclonal Gammopathy of Undetermined Significance: Results of the Prospective Population-Based Istopmm Study","volume":"140","author":"Sverrisdottir","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2023.05.006_bib0395","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood-2010-01-262394","article-title":"Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women","volume":"116","author":"Landgren","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2023.05.006_bib0400","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/bloodadvances.2017007609","article-title":"Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: A population-based study","volume":"1","author":"Thordardottir","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.medcli.2023.05.006_bib0405","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S2352-3026(14)00037-4","article-title":"Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: Apopulation-based retrospective cohort study","volume":"2","author":"Chang","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.medcli.2023.05.006_bib0410","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3324\/haematol.2017.163766","article-title":"The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma","volume":"102","author":"Mikulasova","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.medcli.2023.05.006_bib0415","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1158\/1078-0432.CCR-10-1066","article-title":"The Progression from MGUS to Smoldering Myeloma and Eventually to Multiple Myeloma Involves a Clonal Expansion of Genetically Abnormal Plasma Cells","volume":"17","author":"L\u00f3pez-Corral","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.medcli.2023.05.006_bib0420","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1038\/leu.2012.128","article-title":"SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status","volume":"26","author":"L\u00f3pez-Corral","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.medcli.2023.05.006_bib0425","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cancergencyto.2006.04.009","article-title":"6q deletion discriminates Waldenstr\u00f6m macroglobulinemia from IgM monoclonal gammopathy of undetermined significance","volume":"169","author":"Schop","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.medcli.2023.05.006_bib0430","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2010.11.003","article-title":"Pathogenesis of Monoclonal Gammopathy of Undetermined Significance and Progression to Multiple Myeloma","volume":"48","author":"Zingone","year":"2011","journal-title":"Sem Hematol"},{"key":"10.1016\/j.medcli.2023.05.006_bib0435","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3324\/haematol.2017.172718","article-title":"Pattern of somatic mutations in patients with Waldenstr\u00f6m macroglobulinemia or IgM monoclonal gammopathy of undetermined significance","volume":"102","author":"Varettoni","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.medcli.2023.05.006_bib0440","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/MOH.0000000000000259","article-title":"Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma","volume":"23","author":"Manier","year":"2016","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.medcli.2023.05.006_bib0445","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2023.05.006_bib0450","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2023.05.006_bib0455","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4065\/82.4.428","article-title":"Monoclonal Gammopathy of Undetermined Significance: Predictors of Malignant Transformation and Recognition of an Evolving Type Characterized by a Progressive Increase in M Protein Size","volume":"82","author":"Rosi\u00f1ol","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.medcli.2023.05.006_bib0460","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1182\/blood-2007-05-088443","article-title":"New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells","volume":"110","author":"P\u00e9rez-Persona","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2023.05.006_bib0465","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"JCO"},{"key":"10.1016\/j.medcli.2023.05.006_bib0470","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1053\/sonc.2003.50062","article-title":"Long-term follow-up of IgM monoclonal gammopathy of undetermined significance","volume":"30","author":"Kyle","year":"2003","journal-title":"Sem Oncolo"},{"key":"10.1016\/j.medcli.2023.05.006_bib0475","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12254-020-00630-z","article-title":"Monoclonal gammopathy of undetermined significance (MGUS): Where is the hidden danger? Definition and work-up","volume":"14","author":"Jeryczynski","year":"2021","journal-title":"memo - Magazine of European Medical Oncology"},{"key":"10.1016\/j.medcli.2023.05.006_bib0480","doi-asserted-by":"crossref","first-page":"1045002","DOI":"10.3389\/fimmu.2022.1045002","article-title":"Monoclonal gammopathies of clinical significance (MGCS): In pursuit of optimal treatment","volume":"13","author":"Oganesyan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.medcli.2023.05.006_bib0485","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1182\/blood-2013-05-495929","article-title":"How I treat monoclonal gammopathy of renal significance (MGRS)","volume":"122","author":"Fermand","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2023.05.006_bib0490","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.mayocp.2017.02.003","article-title":"Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and Management","volume":"92","author":"Chaudhry","year":"2017","journal-title":"May Clin Proc"},{"key":"10.1016\/j.medcli.2023.05.006_bib0495","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3324\/haematol.2013.100552","article-title":"The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: Recommendations from the European Myeloma Network","volume":"99","author":"Van de Donk","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.medcli.2023.05.006_bib0500","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.medcli.2023.05.006_bib0505","doi-asserted-by":"crossref","first-page":"123","DOI":"10.14740\/jh1038","article-title":"Treatment of Light Chain Deposition Disease: A Systematic Review","volume":"11","author":"Masood","year":"2022","journal-title":"J Hematol"},{"key":"10.1016\/j.medcli.2023.05.006_bib0510","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1182\/bloodadvances.2020001553","article-title":"Daratumumab in light chain deposition disease: Rapid and profound hematologic response preserves kidney function","volume":"4","author":"Milani","year":"2020","journal-title":"Blood Adv"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775323002890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775323002890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:56:35Z","timestamp":1758419795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775323002890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0025775323002890"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2023.05.006","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gammapat\u00eda monoclonal de significado incierto","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2023.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}